A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mirabegron D5 | CAS 1258889-45-0 - Request Quote

Picture of Mirabegron D5

Mirabegron D5

SZ CAT No:SZ-M035D01
CAS No
1258889-45-0
Mol.F.
C21H19D5N4O2S
Mol.Wt.
401.5
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Mirabegron D5 is chemically (R)-2-(2-Aminothiazol-4-yl)-N-(4-(2-((2-hydroxy-2-(phenyl-d5)ethyl)amino)ethyl)phenyl)acetamide. Mirabegron D5 is supplied with detailed characterization data compliant with regulatory guideline. Mirabegron D5 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Mirabegron.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1258889-45-0

Purchase 1258889-45-0

Order 1258889-45-0

Enquire 1258889-45-0

price of 1258889-45-0

1258889-45-0 Supplier

1258889-45-0 Manufacturer

1258889-45-0 Exporter

buy high quality Mirabegron D5

Purchase Mirabegron D5

Mirabegron D5 suppliers

Mirabegron D5 manufacturers

Mirabegron D5 price

Order Mirabegron D5

Enquire Mirabegron D5

Mirabegron D5 cost

Mirabegron D5 Supplier

Mirabegron D5 Distributor

Mirabegron D5 for Method Validation

Mirabegron Reference Standard

Mirabegron D5 for ANDA Filing

Mirabegron D5 for Forced Degradation Studies

Mirabegron D5 Identification Standards

Mirabegron D5 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,